Pierre FENAUX, MD/PhD
Hôpital Saint Louis
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pierre FENAUX, MD/PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:15 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05935202 · Safety and Efficacy of Mitapivat Sulfate in Adult Patients With Erythrocyte MembranopathiesEuroBloodNet Association · not yet recruiting · Hereditary Red Blood Cell Disorder (Disorder) · study chair
- Ph2NCT05768711 · Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)Groupe Francophone des Myelodysplasies · active not recruiting · Chronic Myeloid Leukemia · principal investigator
- Ph1NCT02323139 · A Study of LDE255 in Combination With Azacitidine for High Risk Myelodysplastic Syndrome PatientsGroupe Francophone des Myelodysplasies · completed · MDS
- Ph1/Ph2NCT02323178 · A Study of Eltrombopag in Patients With CMML and ThrombocytopeniaGroupe Francophone des Myelodysplasies · completed · CMML, Thrombocytopenia
- Ph2NCT01342692 · Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic SyndromesAssistance Publique - Hôpitaux de Paris · unknown · MDS
- Ph2NCT00241241 · Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia VeraPV-Nord · completed · Polycythemia Vera
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:15 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.